CeCors Inc
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional m… Read more
CeCors Inc (CEOS) - Total Assets
Latest total assets as of June 2024: $2.70 Million USD
Based on the latest financial reports, CeCors Inc (CEOS) holds total assets worth $2.70 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CeCors Inc - Total Assets Trend (2004–2024)
This chart illustrates how CeCors Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CeCors Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
CeCors Inc's total assets of $2.70 Million consist of 58.4% current assets and 41.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 55.1% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $45.85K | 1.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $1.29 Million | 31.2% |
Asset Composition Trend (2004–2024)
This chart illustrates how CeCors Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CeCors Inc's current assets represent 58.4% of total assets in 2024, an increase from 17.9% in 2004.
- Cash Position: Cash and equivalents constituted 55.1% of total assets in 2024, up from 17.9% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is goodwill at 31.2% of total assets.
CeCors Inc Competitors by Total Assets
Key competitors of CeCors Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
CeCors Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - CeCors Inc generates 1.53x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CeCors Inc is currently not profitable relative to its asset base.
CeCors Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.39 | 0.13 | 2.34 |
| Quick Ratio | 0.38 | 0.08 | 2.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.81 Million | $ -950.07K | $ 1.60 Million |
CeCors Inc - Advanced Valuation Insights
This section examines the relationship between CeCors Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 138.4% |
| Total Assets | $4.12 Million |
| Market Capitalization | $49.69 USD |
Valuation Analysis
Below Book Valuation: The market values CeCors Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: CeCors Inc's assets grew by 138.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for CeCors Inc (2004–2024)
The table below shows the annual total assets of CeCors Inc from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.12 Million | +138.39% |
| 2023-12-31 | $1.73 Million | +200.43% |
| 2022-12-31 | $574.97K | -8.26% |
| 2021-12-31 | $626.71K | +199.38% |
| 2019-12-31 | $209.34K | 0.00% |
| 2018-12-31 | $209.34K | -78.96% |
| 2016-12-31 | $995.00K | -15.32% |
| 2015-12-31 | $1.18 Million | -13.17% |
| 2014-12-31 | $1.35 Million | -40.07% |
| 2007-12-31 | $2.26 Million | -71.26% |
| 2006-12-31 | $7.86 Million | +180818.35% |
| 2005-12-31 | $4.34K | -92.66% |
| 2004-12-31 | $59.15K | -- |